Results 61 to 70 of about 37,327 (207)

Avaliação etiológica da hipertirotropinemia em crianças com síndrome de Down Etiological assessment of hyperthyrotropinemia in children with Down's syndrome

Jornal de Pediatria, 2005
OBJETIVO: Analisar a prevalência de hipertirotropinemia e estudar sua possível etiologia em crianças com síndrome de Down atendidas na Policlínica Municipal Antônio Cândido, em Belo Horizonte.
Vera M. A. Dias, Júlio C. R. Nunes, Sabrina S. Araújo, Eugênio M. A. Goulart   +3 more
doaj   +1 more source

Plasma total homocysteine, high-sensitivity c-reactive protein and thyroid function in metabolic syndrome patients

Nigerian Postgraduate Medical Journal, 2013
Aims and Objectives : The aim of our study was to examine the levels of thyroid hormones, total plasma homocysteine and C-reactive protein in metabolic syndrome patients and assess the possibility of an association between these four risk factors for ...
C G Orluwene, M O Mommoh
doaj  

Adherence to Levothyroxine Treatment Among Patients With Hypothyroidism: A Northeastern Italian Survey

Frontiers in Endocrinology, 2018
Background: A significant number of patients show sub-optimal adherence to levothyroxine (LT4) therapy, mainly because they have to postpone their breakfast by at least 30 min.
Carlo Cappelli, Roberto Castello, Fiorella Marini, Agostino Paoletta, Massimo Marchetti, Maura Saullo, Alessandra Cristiano, Ilenia Pirola, Elena Gandossi, Alberto Ferlin, Maurizio Castellano   +10 more
doaj   +1 more source

Thyrotropin-producing adenoma: diagnostic challenges (Сase report)

, 2011
Pituitary thyrotropin-producing adenomas (TSH-omas) are rare tumors that cause hyperthyroidism. Failure to recognize this disease may result in dramatic consequences, such as improper thyroid ablation in patients with central hyperthyroidism.

core   +1 more source

Comparing Blood Pressure in Pregnant Women with Subclinical Hypothyroidism Using Levothyroxine to those with Euthyroid Status

Advanced Biomedical Research
Background: Subclinical hypothyroidism (SCH) is a common condition during pregnancy that can be treated with levothyroxine at a dosage of 0.5–1 mcg/kg/day. If left untreated, the risk of hypertensive disorders of pregnancy increases.
Afsaneh Halili, Mozhgan Kazemzadeh, Alireza Seyfi Ardali, Seyede Shahrbanoo Daniali, Nahid Ardian, Masoomeh Goodarzi-Khoigani   +5 more
doaj   +1 more source

Estimation of indirect reference intervals for serum thyrotropin using hospital records

Asian Journal of Medical Sciences, 2017
Background: Reference intervals of any biochemical analyte serve as an invaluable tool in clinical decision making. The IFCC (International Federation of Clinical Chemistry) guidelines for determining these values are not feasible in some hospital ...
Kushal Bhattarai
doaj   +1 more source

Hepatic hemangioendothelioma associated with production of humoral thyrotropin-like factor

, 2001
We report on 7 patients referred for treatment of hepatic hemangioendothelioma with increased thyrotropin levels. The serum thyroxine level was decreased in 4 and increased in 2.
Metcalfe, R, Davenport, M, Mark Davenport, Mieli-Vergani, G, Howard, E R, Russell Metcalfe, Ayling, R M, Charles R. Buchanan, Buchanan, C R, Hadzic, N, Giorgina Mieli-Vergani, Ruth M. Ayling, Nedim Hadzic, Edward R. Howard   +13 more
core   +1 more source

Central autonomic pharmacology of thyrotropin releasing hormone [PDF]

, 1987
Thyrotropin releasing hormone (TRH, I-pyroglutamyl-l-histidyl-l-prolinamide) was the fIrst hypothalamic releasing SUbstance to be isolated, chemically characterized and synthetized /1/.
Feuerstein, Giera, Sirén, Anna-Leena
core   +2 more sources

Synthesis of Analogues of Thyrotropin-Releasing Hormone

, 1994
The synthesis of ten new thyrotropin-releasing hormone analogues (15-24) which contain uncoded amino acids (L- and D-homoleucine, L- and D-homophenylalanine, L-homoproline and 6-ketopipecolic acid) is described here.
Baláspiri L, Somlai Csaba
core   +1 more source

Recombinant human thyrotropin in veterinary medicine: current use and future perspectives [PDF]

, 2012
Recombinant human thyrotropin (rhTSH) was developed after bovine thyrotropin (bTSH) was no longer commercially available. It was approved by the Food and Drug Administration (FDA) and the European Medicines Agency (EMEA) as an aid to diagnostic follow-up
van Hoeck, I, Peremans, Kathelijne, Daminet, S, Daminet, Sylvie, Peremans, K, Campos, Miguel, van Hoek, I   +6 more
core   +1 more source